Article
Systemic Administration of AAV9-G266A with Focused Ultrasound Enables Robust Brain Transduction with Minimal Liver Transduction.
Human gene therapy - 1 Mar 2026
Nelson Andrew T, Smith Aidan, Curley Colleen T, Kelly Brian, Ganesh Ahil N, Peterson Drew, Fabyanic Emily, Kostuk Eric, Weber Thomas, Engel Esteban A
Abstract excerpt
Systemic delivery of adeno-associated viral (AAV) vectors is a promising approach for brain gene therapy, particularly in combination with emerging techniques such as focused ultrasound (FUS), which can transiently and noninvasively open the blood-brain barrier to facilitate delivery of AAVs to the brain. However, off-target vector accumulation, particularly in the liver, remains a significant safety concern. To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
